Hylosept

Fusidic Acid, the active ingredient in Hylosept, is an antibiotic presented as a topical formulation for skin application. It treats bacterial skin infections caused by susceptible Gram‑positive organisms, particularly Staphylococcus aureus, in both adults and children.

GNH USA supplies Hylosept as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Fusidic Acid is applied topically to manage bacterial skin infections.

Impetigo: reduces bacterial load and promotes healing of superficial lesions. Infected eczema or dermatitis: controls bacterial overgrowth and alleviates inflammation. Secondary infection of cuts, abrasions or wounds: prevents bacterial colonisation and supports tissue repair. Infected minor burns: limits bacterial spread and aids recovery.

Fusidic Acid may cause local skin reactions when applied.

Common Side Effects: - Mild irritation or burning at the application site. - Itching or pruritus. - Redness or erythema. - Dryness or flaking of the skin. - Contact dermatitis. - Minor swelling.

Serious or Rare Side Effects: - Allergic reaction with hives or swelling. - Severe skin rash or Stevens‑Johnson syndrome. - Anaphylaxis. - Extensive blistering or necrosis. - Systemic hypersensitivity. - Persistent ulceration at the site.

Before using Hylosept, consider the following safety measures.

Pregnancy: consult a healthcare professional before use. Breastfeeding: safety not established; use only if benefits outweigh risks. Allergy: avoid if known hypersensitivity to fusidic acid or excipients. Extended use: limit duration to reduce risk of bacterial resistance. Pediatric use: follow prescriber guidance for children. Store at below 25°C: keep in the original container, protect from moisture and light.

Fusidic Acid may interact with other agents; monitor accordingly.

Major Interactions (Avoid): - Systemic corticosteroids: may increase infection risk. - Concurrent use of other topical antibiotics: can cause additive skin irritation.

Moderate Interactions (Monitor Closely): - Topical antifungal agents: may reduce antibacterial effectiveness. - Retinoids or vitamin A derivatives: may heighten local irritation. - Occlusive dressings: can increase drug absorption and local concentration.